Papers/PMID:24635480
Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.
Journal of clinical pharmacy and therapeutics2014The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
chromium(3+) — decreases triglycerides
Evidence strength: very limited.Findingreplicated ×2“In particular, chromium monotherapy significantly reduced triglycerides and increased HDL-C levels.”
Quoted verbatim from Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.. - Study
- meta-analysis
- Population
- Patients with diabetes mellitus, chromium monosupplementation trials against placebo
Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.2014PMID:2463548010.1111/jcpt.12147Permalink
chromium(3+) — increases HDL cholesterol
Evidence strength: very limited.Findingreplicated ×1“In particular, chromium monotherapy significantly reduced triglycerides and increased HDL-C levels.”
Quoted verbatim from Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.. - Study
- meta-analysis
- Population
- Patients with diabetes mellitus, chromium monosupplementation trials against placebo
Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.2014PMID:2463548010.1111/jcpt.12147Permalink